Oscar Health (NYSE:OSCR) Coverage Initiated by Analysts at Barclays

Analysts at Barclays initiated coverage on shares of Oscar Health (NYSE:OSCR - Get Free Report) in a report issued on Wednesday, MarketBeat.com reports. The brokerage set an "underweight" rating and a $17.00 price target on the stock. Barclays's price target suggests a potential upside of 3.58% from the stock's previous close.

A number of other research analysts have also recently commented on OSCR. Wall Street Zen cut Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Piper Sandler decreased their target price on Oscar Health from $25.00 to $18.00 and set an "overweight" rating on the stock in a research report on Monday, June 9th. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Finally, Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Three research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $16.58.

Oscar Health Price Performance

Shares of NYSE OSCR traded down $0.21 during mid-day trading on Wednesday, reaching $16.41. The company had a trading volume of 24,442,422 shares, compared to its average volume of 6,224,949. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88. Oscar Health has a one year low of $11.20 and a one year high of $23.79. The firm has a market cap of $4.18 billion, a price-to-earnings ratio of 58.66 and a beta of 1.90. The business's 50-day simple moving average is $15.84 and its 200 day simple moving average is $14.76.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter last year, the business earned $0.62 earnings per share. Oscar Health's revenue was up 42.2% on a year-over-year basis. On average, research analysts predict that Oscar Health will post 0.69 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director directly owned 64,512 shares of the company's stock, valued at $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 24.39% of the company's stock.

Hedge Funds Weigh In On Oscar Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Jones Financial Companies Lllp lifted its stake in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio acquired a new position in Oscar Health in the first quarter valued at approximately $30,000. Larson Financial Group LLC lifted its stake in Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after buying an additional 2,512 shares during the period. CWM LLC lifted its stake in Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Oscar Health by 484.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock valued at $45,000 after buying an additional 2,854 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.